| |
| |
|
| Insider
Information: |
Kruse Bo |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
210,877 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,446,173 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
210,877 |
|
|
| Total
Value |
$2,446,173 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 90.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Y-Mabs Therapeutics Inc |
YMAB |
|
2024-01-18 |
210,877 |
2020-05-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, SECRY & TREAS. |
• – – |
2024-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
18,100 |
210,877 |
0 |
- |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secry & Treas. |
• – – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
11,700 |
192,777 |
0 |
- |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2022-02-22 |
4 |
AS |
$7.85 |
$31,400 |
D/D |
(4,000) |
181,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas |
• – – |
2022-02-04 |
4 |
AS |
$7.97 |
$31,880 |
D/D |
(4,000) |
185,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2022-01-24 |
4 |
AS |
$9.84 |
$39,360 |
D/D |
(4,000) |
189,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2022-01-04 |
4 |
AS |
$17.12 |
$68,480 |
D/D |
(4,000) |
193,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2021-12-22 |
4 |
AS |
$16.36 |
$65,440 |
D/D |
(4,000) |
197,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2021-12-06 |
4 |
AS |
$16.35 |
$65,400 |
D/D |
(4,000) |
201,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2021-11-04 |
4 |
AS |
$27.54 |
$110,160 |
D/D |
(4,000) |
209,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2021-10-22 |
4 |
AS |
$25.94 |
$103,760 |
D/D |
(4,000) |
213,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2021-10-04 |
4 |
AS |
$28.78 |
$115,120 |
D/D |
(4,000) |
217,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2021-09-22 |
4 |
AS |
$30.82 |
$123,280 |
D/D |
(4,000) |
221,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2021-09-07 |
4 |
AS |
$32.03 |
$128,120 |
D/D |
(4,000) |
225,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2021-08-23 |
4 |
AS |
$28.60 |
$114,400 |
D/D |
(4,000) |
229,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2021-08-04 |
4 |
AS |
$33.72 |
$134,880 |
D/D |
(4,000) |
233,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2021-07-22 |
4 |
AS |
$34.50 |
$138,000 |
D/D |
(4,000) |
237,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2021-07-06 |
4 |
AS |
$34.15 |
$136,600 |
D/D |
(4,000) |
241,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2021-06-22 |
4 |
AS |
$36.17 |
$144,680 |
D/D |
(4,000) |
245,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2021-06-04 |
4 |
AS |
$33.48 |
$133,920 |
D/D |
(4,000) |
249,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secretary & Treas. |
• – – |
2021-05-24 |
4 |
AS |
$35.61 |
$142,440 |
D/D |
(4,000) |
253,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secy & Treas. |
• – – |
2020-05-14 |
4 |
S |
$36.03 |
$1,363,533 |
I/I |
(37,847) |
0 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secy & Treas. |
• – – |
2020-05-14 |
4 |
S |
$36.03 |
$1,015,872 |
D/D |
(28,199) |
257,077 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secy & Treas. |
• – – |
2020-05-13 |
4 |
S |
$37.88 |
$728,400 |
I/I |
(19,230) |
37,847 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
EVP, CFO, Secy & Treas. |
• – – |
2020-05-13 |
4 |
S |
$37.86 |
$557,517 |
D/D |
(14,724) |
285,276 |
0 |
% |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
